Logo image of PEPG

PEPGEN INC (PEPG) Stock Fundamental Analysis

USA - NASDAQ:PEPG - US7133171055 - Common Stock

4.91 USD
-0.05 (-1.01%)
Last: 10/7/2025, 8:00:01 PM
5 USD
+0.09 (+1.83%)
Pre-Market: 10/8/2025, 8:00:05 AM
Fundamental Rating

2

Overall PEPG gets a fundamental rating of 2 out of 10. We evaluated PEPG against 536 industry peers in the Biotechnology industry. The financial health of PEPG is average, but there are quite some concerns on its profitability. PEPG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

PEPG had negative earnings in the past year.
PEPG had a negative operating cash flow in the past year.
In the past 5 years PEPG always reported negative net income.
PEPG had a negative operating cash flow in each of the past 5 years.
PEPG Yearly Net Income VS EBIT VS OCF VS FCFPEPG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

The Return On Assets of PEPG (-94.79%) is worse than 73.88% of its industry peers.
PEPG has a worse Return On Equity (-136.20%) than 61.19% of its industry peers.
Industry RankSector Rank
ROA -94.79%
ROE -136.2%
ROIC N/A
ROA(3y)-48.79%
ROA(5y)-36.64%
ROE(3y)-62.28%
ROE(5y)-45.33%
ROIC(3y)N/A
ROIC(5y)N/A
PEPG Yearly ROA, ROE, ROICPEPG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

PEPG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PEPG Yearly Profit, Operating, Gross MarginsPEPG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for PEPG has been increased compared to 1 year ago.
Compared to 5 years ago, PEPG has more shares outstanding
There is no outstanding debt for PEPG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PEPG Yearly Shares OutstandingPEPG Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M
PEPG Yearly Total Debt VS Total AssetsPEPG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -0.53, we must say that PEPG is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.53, PEPG perfoms like the industry average, outperforming 56.72% of the companies in the same industry.
PEPG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.53
ROIC/WACCN/A
WACCN/A
PEPG Yearly LT Debt VS Equity VS FCFPEPG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 4.74 indicates that PEPG has no problem at all paying its short term obligations.
The Current ratio of PEPG (4.74) is comparable to the rest of the industry.
PEPG has a Quick Ratio of 4.74. This indicates that PEPG is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of PEPG (4.74) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 4.74
Quick Ratio 4.74
PEPG Yearly Current Assets VS Current LiabilitesPEPG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.97% over the past year.
EPS 1Y (TTM)9.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.54%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

PEPG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.66% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y6.61%
EPS Next 2Y17.05%
EPS Next 3Y11.6%
EPS Next 5Y14.66%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PEPG Yearly Revenue VS EstimatesPEPG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
PEPG Yearly EPS VS EstimatesPEPG Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -5 -10 -15 -20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

PEPG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PEPG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PEPG Price Earnings VS Forward Price EarningsPEPG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PEPG Per share dataPEPG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.05%
EPS Next 3Y11.6%

More info and screens

0

5. Dividend

5.1 Amount

PEPG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PEPGEN INC

NASDAQ:PEPG (10/7/2025, 8:00:01 PM)

Premarket: 5 +0.09 (+1.83%)

4.91

-0.05 (-1.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05
Inst Owners89.49%
Inst Owner Change0%
Ins Owners0.27%
Ins Owner Change5.36%
Market Cap337.51M
Analysts85
Price Target8.5 (73.12%)
Short Float %3.44%
Short Ratio0.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.1%
Min EPS beat(2)-25.27%
Max EPS beat(2)17.07%
EPS beat(4)3
Avg EPS beat(4)8.74%
Min EPS beat(4)-25.27%
Max EPS beat(4)25.45%
EPS beat(8)5
Avg EPS beat(8)5.7%
EPS beat(12)9
Avg EPS beat(12)13.04%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)19.05%
PT rev (3m)-16.67%
EPS NQ rev (1m)20.44%
EPS NQ rev (3m)25.11%
EPS NY rev (1m)8.7%
EPS NY rev (3m)7.93%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.74
P/tB 4.74
EV/EBITDA N/A
EPS(TTM)-2.96
EYN/A
EPS(NY)-1.79
Fwd EYN/A
FCF(TTM)-1.32
FCFYN/A
OCF(TTM)-1.31
OCFYN/A
SpS0
BVpS1.04
TBVpS1.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -94.79%
ROE -136.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-48.79%
ROA(5y)-36.64%
ROE(3y)-62.28%
ROE(5y)-45.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 39.23%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.74
Quick Ratio 4.74
Altman-Z -0.53
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)339.96%
Cap/Depr(5y)261.35%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.54%
EPS Next Y6.61%
EPS Next 2Y17.05%
EPS Next 3Y11.6%
EPS Next 5Y14.66%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-7.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1.71%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.44%
OCF growth 3YN/A
OCF growth 5YN/A